RVPH — Reviva Pharmaceuticals Holdings,. Cashflow Statement
0.000.00%
Last trade - 00:00- $84.31m
- $60.95m
Annual cashflow statement for Reviva Pharmaceuticals Holdings,., fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 February 28th | 2020 February 29th | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | USG | USG | USG | — | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 0.574 | 0.618 | -8.52 | -24.3 | — |
| Depreciation | |||||
| Non-Cash Items | -0.727 | -1.34 | -1.44 | 0.371 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.068 | 0.298 | -0.702 | 5.01 | — |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.221 | -0.427 | -10.7 | -19 | — |
| Other Investing Cash Flow Items | -64.5 | 5.7 | — | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -64.5 | 5.7 | — | — | — |
| Financing Cash Flow Items | -0.391 | 0 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 65 | -5.52 | 31.6 | 7.79 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.313 | -0.244 | 20.9 | -11.2 | — |